PORTON BIOPHARMA LIMITED

Company number 09331560

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
14 Jul 2020 TM01 Termination of appointment of Donald Richard Gleave as a director on 14 July 2020
11 Jun 2020 AP01 Appointment of Mr Bruce Philip Pritchard as a director on 1 June 2020
09 Jun 2020 AP01 Appointment of Mr Martin Andrews as a director on 1 June 2020
14 Apr 2020 SH01 Statement of capital following an allotment of shares on 31 March 2020
  • GBP 76,476,000
06 Apr 2020 CH01 Director's details changed for Donald Richard Gleave on 3 April 2020
06 Apr 2020 CH01 Director's details changed for Roger James Hinton on 3 April 2020
14 Feb 2020 AP01 Appointment of Ms Rebecca Wilson as a director on 11 February 2020
23 Dec 2019 AA Full accounts made up to 31 March 2019
27 Nov 2019 CS01 Confirmation statement made on 27 November 2019 with updates
14 Nov 2019 AP01 Appointment of Mr Donald Anthony Shepherd as a director on 12 November 2019
01 Nov 2019 TM01 Termination of appointment of Martin Hindle as a director on 31 October 2019
02 Sep 2019 TM01 Termination of appointment of Michael Brodie as a director on 30 August 2019
29 Jul 2019 TM01 Termination of appointment of Nigel Stanley Brooksby as a director on 30 June 2019
27 Mar 2019 SH01 Statement of capital following an allotment of shares on 13 March 2019
  • GBP 67,976,000
15 Feb 2019 TM01 Termination of appointment of Michael Harrison as a director on 15 February 2019
08 Jan 2019 AP01 Appointment of Mr Barry Clare as a director on 3 December 2018
28 Nov 2018 CS01 Confirmation statement made on 27 November 2018 with updates
22 Aug 2018 AA Full accounts made up to 31 March 2018
15 May 2018 SH01 Statement of capital following an allotment of shares on 16 March 2018
  • GBP 58,976,000
10 Jan 2018 SH01 Statement of capital following an allotment of shares on 22 December 2017
  • GBP 53,576,000
29 Dec 2017 AA Full accounts made up to 31 March 2017
19 Dec 2017 SH01 Statement of capital following an allotment of shares on 2 October 2017
  • GBP 51,884,000
30 Nov 2017 CS01 Confirmation statement made on 27 November 2017 with updates
16 May 2017 SH01 Statement of capital following an allotment of shares on 14 March 2017
  • GBP 46,384,000
16 May 2017 AP01 Appointment of Mr Michael Harrison as a director on 8 May 2017